Cell and gene therapy in the treatment of pain

Advanced Drug Delivery Reviews

Volumn 55, Issue 8, 2003, Pages 1055-1064

  Fink, David ^a,c,d   Mata, Marina ^a,c   Glorioso, Joseph C ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NONE   (United States)

Author keywords

Adenovirus; Chromaffin cell; Gene therapy; Herpes simplex virus; Pain

Indexed keywords

CYTOLOGY; GENES; MACROMOLECULES; NEUROLOGY; VIRUSES;

PEPTIDES;

DRUG THERAPY;

ANALGESIC AGENT; BETA ENDORPHIN; LEUCINE ENKEPHALIN; METENKEPHALIN; NALOXONE; OPIATE ANTAGONIST; PROENKEPHALIN; VIRUS DNA; VIRUS VECTOR;

ADENOVIRUS; ADOPTIVE IMMUNOTHERAPY; ANALGESIA; ANIMAL MODEL; BRAIN NERVE CELL; CELL TRANSPLANTATION; CHROMAFFIN CELL; COGNITIVE DEFECT; CONSTIPATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX VIRUS; HUMAN; MENINX; MOOD DISORDER; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SPINAL CORD; URINE RETENTION;

EID: 0142186829     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(03)00103-0     Document Type: Article

References (31)

1. Wilson S.P., Chang K.J., Viveros O.H. Opioid peptide synthesis in bovine and human adrenal chromaffin cells. Peptides. 2:(Suppl. 1):1981;83-88.
2. Unsicker K. The trophic cocktail made by adrenal chromaffin cells. Exp. Neurol. 123:(2):1993;167-173.
3. Hama A.T., Sagen J. Alleviation of neuropathic pain symptoms by xenogeneic chromaffin cell grafts in the spinal subarachnoid space. Brain Res. 651:(1-2):1994;183-193.
4. Siegan J.B., Sagen J. Attenuation of formalin pain responses in the rat by adrenal medullary transplants in the spinal subarachnoid space. Pain. 70:(2-3):1997;279-285.
5. Sagen J., Wang H. Adrenal medullary grafts suppress c-fos induction in spinal neurons of arthritic rats. Neurosci. Lett. 192:(3):1995;181-184.
6. Ibuki T., Hama A.T., Wang X.T., Pappas G.D., Sagen J. Loss of GABA-immunoreactivity in the spinal dorsal horn of rats with peripheral nerve injury and promotion of recovery by adrenal medullary grafts. Neuroscience. 76:(3):1997;845-858.
7. Sagen J., Kemmler J.E. Increased levels of Met-enkephalin-like immunoreactivity in the spinal cord CSF of rats with adrenal medullary transplants. Brain Res. 502:(1):1989;1-10.
8. Sagen J., Kemmler J.E., Wang H. Adrenal medullary transplants increase spinal cord cerebrospinal fluid catecholamine levels and reduce pain sensitivity. J. Neurochem. 56:(2):1991;623-627.
9. Hentall I.D., Noga B.R., Sagen J. Spinal allografts of adrenal medulla block nociceptive facilitation in the dorsal horn. J. Neurophysiol. 85:(4):2001;1788-1792.
10. Wu H.H., Wilcox G.L., McLoon S.C. Implantation of AtT-20 or genetically modified AtT-20/hENK cells in mouse spinal cord induced antinociception and opioid tolerance. J. Neurosci. 14:(8):1994;4806-4814.
11. Wang H., Sagen J. Absence of appreciable tolerance and morphine cross-tolerance in rats with adrenal medullary transplants in the spinal cord. Neuropharmacology. 33:(5):1994;681-692.
12. Eaton M.J., Karmally S., Martinez M.A., Plunkett J.A., Lopez T., Cejas P.J. Lumbar transplant of neurons genetically modified to secrete galanin reverse pain-like behaviors after partial sciatic nerve injury. J. Peripher. Nerv. Syst. 4:(3-4):1999;245-257.
13. Eaton M.J., Plunkett J.A., Martinez M.A., Lopez T., Karmally S., Cejas P., et al. Transplants of neuronal cells bioengineered to synthesize GABA alleviate chronic neuropathic pain. Cell Transplant. 8:(1):1999;87-101.
14. Cejas P.J., Martinez M., Karmally S., McKillop M., McKillop J., Plunkett J.A., et al. Lumbar transplant of neurons genetically modified to secrete brain-derived neurotrophic factor attenuates allodynia and hyperalgesia after sciatic nerve constriction. Pain. 86:(1-2):2000;195-210.
15. Buchser E., Goddard M., Heyd B., Joseph J.M., Favre J., de Tribolet N., et al. Immunoisolated xenogenic chromaffin cell therapy for chronic pain. Initial clinical experience. Anesthesiology. 85:(5):1996;1005-1012. discussion 29A-30A.
16. Finegold A.A., Mannes A.J., Iadarola M.J. A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain. Hum. Gene Ther. 10:(7):1999;1251-1257.
17. Spear P.G., Eisenberg R.J., Cohen G.H. Three classes of cell surface receptors for alphaherpesvirus entry. Virology. 275:(1):2000;1-8.
18. Shukla D., Spear P.G. Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J. Clin. Invest. 108:(4):2001;503-510.
19. Smith G.A., Enquist L.W. Break ins and break outs: Viral interactions with the cytoskeleton of mammalian cells. Annu. Rev. Cell Dev. Biol. 18:2002;135-161.
20. Antunes Bras J.M., Epstein A.L., Bourgoin S., Hamon M., Cesselin F., Pohl M. Herpes simplex virus 1-mediated transfer of preproenkephalin A in rat dorsal root ganglia. J. Neurochem. 70:(3):1998;1299-1303.
21. Antunes bras J., Becker C., Bourgoin S., Lombard M., Cesselin F., Hamon M., et al. Met-enkephalin is preferentially transported into the peripheral processes of primary afferent fibres in both control and HSV1-driven proenkephalin A overexpressing rats. Neuroscience. 103:(4):2001;1073-1083.
22. Wilson S.P., Yeomans D.C., Bender M.A., Lu Y., Goins W.F., Glorioso J.C. Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proc. Natl. Acad. Sci. USA. 96:(6):1999;3211-3216.
23. DeLuca N.A., McCarthy A.M., Schaffer P.A. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J. Virol. 56:1985;558-570.
24. Goss J.R., Mata M., Goins W.F., Wu H.H., Glorioso J.C., Fink D.J. Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther. 8:(7):2001;551-556.
25. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:(3):1992;355-363.
26. Hao S., Mata M., Goins W., Glorioso J.C., Fink D.J. Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect. Pain. 102:2003;135-142.
27. Schwei M.J., Honore P., Rogers S.D., Salak-Johnson J.L., Finke M.P., Ramnaraine M.L., et al. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J. Neurosci. 19:(24):1999;10886- 10897.
28. Goss J.R., Harley C.F., Mata M., O'Malley M.E., Goins W.F., Hu X.-P., et al. Herpes vector-mediated expression of proenkephalin reduces pain-related behavior in a model of bone cancer pain. Ann. Neurol. 52:2002;662-665.
29. Braz J., Beaufour C., Coutaux A., Epstein A.L., Cesselin F., Hamon M., et al. Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. J. Neurosci. 21:(20):2001;7881- 7888.
30. Kang W., Wilson M.A., Bender M.A., Glorioso J.C., Wilson S.P. Herpes virus-mediated preproenkephalin gene transfer to the amygdala is antinociceptive. Brain Res. 792:(1):1998;133-135.
31. Chen X., Li J., Mata M., Goss J., Wolfe D., Glorioso J.C., et al. Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture. J. Virol. 74:(21):2000;10132-10141.